4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-005745
EVP, Research & CSO sold 31,300 shares at $48.17 ($1,507,806)
- EVP, Research & CSO acquired 31,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-01-26 | Option exercise | +31,300 | $1.53 | $47,889 | 64,500 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2021-01-26 | Sale | −31,300 | $48.17 | $1,507,806 | 33,200 | D: show line 2 in the form |
| Open-market sales · 31,300 sh · avg $48.17 · $1,507,806 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-01-26 | Option exercise · Stock Option (Right to Buy) | −31,300 | 380,155 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…